Treximet
- Product NDC
- 65224-850
- 11-digit product format
- 652240850
- Labeler code
- 65224
- Product ID
- 65224-850_146f2017-7356-4ccf-8c0c-65b1eb53df8f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sumatriptan Succinate and Naproxen Sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Pernix Therapeutics
- Application
- NDA021926
- Marketing category
- NDA
- Marketing start
- 2015-05-14
- Marketing end
- 2021-09-30
- Substance
- SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM
- Active strength
- 85 mg/1; mg/1
- Pharmacologic classes
- Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65224-850-09 | 65224085009 | 9 TABLET, FILM COATED in 1 BOTTLE (65224-850-09) | 2015-05-14 | 2021-09-30 | No | No | Current |